GAMMA Investing LLC Has $81,000 Stock Holdings in Option Care Health, Inc. $OPCH

GAMMA Investing LLC lessened its stake in Option Care Health, Inc. (NASDAQ:OPCH) by 21.9% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 2,493 shares of the company’s stock after selling 699 shares during the quarter. GAMMA Investing LLC’s holdings in Option Care Health were worth $81,000 as of its most recent SEC filing.

A number of other large investors have also recently added to or reduced their stakes in the company. Compass Wealth Management LLC lifted its holdings in Option Care Health by 8.9% during the 1st quarter. Compass Wealth Management LLC now owns 166,078 shares of the company’s stock valued at $5,804,000 after purchasing an additional 13,600 shares during the last quarter. Bessemer Group Inc. lifted its holdings in Option Care Health by 62.3% during the 1st quarter. Bessemer Group Inc. now owns 1,560 shares of the company’s stock valued at $54,000 after purchasing an additional 599 shares during the last quarter. Principal Financial Group Inc. lifted its stake in shares of Option Care Health by 1.4% during the 1st quarter. Principal Financial Group Inc. now owns 485,871 shares of the company’s stock worth $16,981,000 after buying an additional 6,616 shares during the last quarter. Wealth Enhancement Advisory Services LLC lifted its stake in shares of Option Care Health by 25.7% during the 1st quarter. Wealth Enhancement Advisory Services LLC now owns 8,274 shares of the company’s stock worth $289,000 after buying an additional 1,691 shares during the last quarter. Finally, Bridges Investment Management Inc. lifted its stake in shares of Option Care Health by 133.3% during the 1st quarter. Bridges Investment Management Inc. now owns 49,031 shares of the company’s stock worth $1,714,000 after buying an additional 28,019 shares during the last quarter. Institutional investors and hedge funds own 98.05% of the company’s stock.

Option Care Health Stock Up 2.2%

Shares of NASDAQ OPCH opened at $27.84 on Friday. The company has a current ratio of 1.52, a quick ratio of 1.00 and a debt-to-equity ratio of 0.81. The company has a market cap of $4.52 billion, a price-to-earnings ratio of 22.27, a PEG ratio of 1.65 and a beta of 0.88. Option Care Health, Inc. has a 12 month low of $21.39 and a 12 month high of $35.53. The stock has a 50-day moving average price of $28.41 and a two-hundred day moving average price of $30.89.

Option Care Health (NASDAQ:OPCH) last announced its quarterly earnings results on Wednesday, July 30th. The company reported $0.41 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.40 by $0.01. Option Care Health had a net margin of 3.93% and a return on equity of 17.53%. The company had revenue of $1.42 billion during the quarter, compared to the consensus estimate of $1.35 billion. During the same period in the prior year, the business earned $0.30 earnings per share. The company’s revenue for the quarter was up 15.4% compared to the same quarter last year. Option Care Health has set its FY 2025 guidance at 1.650-1.720 EPS. As a group, analysts forecast that Option Care Health, Inc. will post 1.22 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

Several brokerages have issued reports on OPCH. JMP Securities raised their price objective on shares of Option Care Health from $36.00 to $38.00 and gave the stock a “market outperform” rating in a research report on Thursday, July 31st. TD Cowen started coverage on Option Care Health in a report on Thursday. They set a “hold” rating and a $30.00 price target for the company. Citigroup reissued an “outperform” rating on shares of Option Care Health in a report on Thursday, July 31st. Barrington Research reissued an “outperform” rating and set a $38.00 price target on shares of Option Care Health in a report on Tuesday, September 23rd. Finally, Cowen started coverage on Option Care Health in a report on Thursday. They set a “hold” rating for the company. Eight analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $35.11.

Insider Transactions at Option Care Health

In other Option Care Health news, Director Norman L. Wright purchased 3,411 shares of the firm’s stock in a transaction on Tuesday, September 9th. The stock was purchased at an average cost of $29.31 per share, for a total transaction of $99,976.41. Following the acquisition, the director owned 15,501 shares in the company, valued at approximately $454,334.31. The trade was a 28.21% increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Timothy P. Sullivan purchased 20,000 shares of the firm’s stock in a transaction on Thursday, August 21st. The shares were acquired at an average price of $27.51 per share, with a total value of $550,200.00. Following the completion of the acquisition, the director owned 49,229 shares in the company, valued at approximately $1,354,289.79. This trade represents a 68.43% increase in their position. The disclosure for this purchase can be found here. Insiders bought a total of 59,411 shares of company stock worth $1,627,576 over the last three months. 0.64% of the stock is owned by company insiders.

Option Care Health Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.